Par Pharmaceutical Promotes Executives

Par Pharmaceutical Companies, Inc. has promoted Thomas J. Haughey to the role of president and Paul V. Campanelli to the role of chief operating officer, effective immediately. Both executives will continue to report to Patrick G. LePore, chairman of the board and chief executive officer.

Since joining the company in 2003, Mr. Haughey has served as chief administrative officer, executive vice president, and general counsel and secretary. Mr. Haughey has more than 25 years of accounting, legal and pharmaceutical experience.

In addition to his title as chief operating officer, Mr. Campanelli will retain the title of president of Par Pharmaceutical and assume responsibility for Strativa Pharmaceuticals, the company’s branded division. Mr. Campanelli joined the company in 2001 as senior director, business development and has held positions of increasing responsibilities.

Mr. LePore said, “With the acquisition of Anchen and the pending acquisition of Edict, Par is becoming a larger and more complex organization with three diverse locations and more than 300 additional employees. These new challenges and opportunities require a president and chief operating officer to effectively manage the Company and its subsidiaries. Tom and Paul have been instrumental in Par’s many successes to date, and these expanded titles are a better reflection of their current responsibilities and achievements.”